Journal Logo

Poster Session I: Acute myeloid leukemia - Biology & translational research

PF204 TARP AS IMMUNOTHERAPEUTIC TARGET IN AML EXPRESSED IN THE LSC COMPARTMENT

Depreter, B.1; Weening, K.2; Vandepoele, K.3; Essand, M.4; De Moerloose, B.5; Themeli, M.6; Cloos, J.6; Hanekamp, D.6; Moors, I.7; D’hont, I.5; Denys, B.3; Uyttebroeck, A.8; Van Damme, A.9; Dedeken, L.10; Snauwaert, S.11; Goetgeluk, G.2; De Munter, S.2; Kerre, T.7; Vandekerckhove, B.2; Lammens, T.1; Philippé, J.3

Author Information
doi: 10.1097/01.HS9.0000559032.62059.eb
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.